This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in 2010. Widespread use of the vaccine throughout much of Africa may prevent more than a million cases of meningitis over the next decade. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): LaForce FM, Okwo-Bele J-M

Published: 2011

Resource types: Peer-reviewed journal

Diseases: Meningococcus

Topics: Introduction and service delivery; Disease/vaccine specific information

Regions: Africa